News Image

Thursday's after hours session: top gainers and losers

By Mill Chart

Last update: Jun 30, 2022

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

Gainers

TickerChangeComment
AKBA54.29%Akebia Therapeutics Inc's (NASDAQ:AKBA) shares rose 54.29% to $0.54. In the last 3 months the share price dropped with 47.12%.
QNRX13.33%Quoin Pharmaceuticals Ltd's (NASDAQ:QNRX) shares rose 13.33% to $0.51 during Thursday's after hours session. The stock is trading 29.36% lower than a month ago.
ENJY9.73%Enjoy Technology Inc's (NASDAQ:ENJY) stock price increased by 9.73% to $0.24. NASDAQ:ENJY seems to be recovering from a -25.21% loss in the regular session.
CYTK7.18%Cytokinetics Inc (NASDAQ:CYTK) rose 7.18% to $42.11 during Thursday's after hours session. Prices are quite volatile here as NASDAQ:CYTK closed with a -19.39% loss today.
FWBI6.25%First Wave BioPharma Inc's (NASDAQ:FWBI) stock price is advancing with 6.25% to a price of $0.21. Prices are quite volatile here as NASDAQ:FWBI closed with a -37.5% loss today.
TOUR5.71%Tuniu Corporation's (NASDAQ:TOUR) shares rose 5.71% to $1.11. Also in the regular session NASDAQ:TOUR had a very good day: shares closed with a 26.51% gain.
CZOO5.56%Cazoo Group Ltd's (NYSE:CZOO) shares rose 5.56% to $0.76. In the last month the share price dropped with 43.75%.
HRTG4.92%Heritage Insurance Holdings Inc's (NYSE:HRTG) shares rose 4.92% to $2.77. Shareholders saw the stock price going 23.48% lower in the past month.
SFT4.48%Shift Technologies Inc's (NASDAQ:SFT) shares rose 4.48% to $0.7. In the last month the stock lost 31.25%.
RGP4.47%Resources Connection Inc (NASDAQ:RGP) rose 4.47% to $21.28 during Thursday's after hours session. Shareholders saw the stock price going 42.95% higher is the past year.

Our after hours gainers screener will show you the full list.

After hours losers

TickerChangeComment
REVB-10.81%Revelation Biosciences Inc's (NASDAQ:REVB) stock price decreased by 10.81% to $0.99. After today's gain of 76.19%, it goes down with 10.81% in today's after hours session.
HTGM-9.7%HTG Molecular Diagnostics Inc's (NASDAQ:HTGM) stock price decreased by 9.7% to $0.93. The stock is trading 86.09% higher than a month ago.
DRMA-7.69%Dermata Therapeutics Inc's (NASDAQ:DRMA) shares fell 7.69% to $0.6 during Thursday's after hours session. After running up 20.37% in today's session, NASDAQ:DRMA is pulling back after hours.
THMO-7.14%ThermoGenesis Holdings Inc's (NASDAQ:THMO) stock price decreased by 7.14% to $0.26. The stock is trading 28.32% lower than a month ago.
KALA-6.67%Kala Pharmaceuticals Inc's (NASDAQ:KALA) stock price is declining with 6.67% to a price of $0.28. In the last 3 months the share price dropped with 77.1%.
GMBL-5.83%Esports Entertainment Group Inc's (NASDAQ:GMBL) stock price decreased by 5.83% to $0.39. In the last 3 months the stock lost 42.42%.
FLL-5.76%Full House Resorts Inc's (NASDAQ:FLL) stock price is declining with 5.76% to a price of $5.73. In the last 3 months the stock lost 36.4%.
CLBS-5.66%Caladrius Biosciences Inc's (NASDAQ:CLBS) shares fell 5.66% to $0.5 during Thursday's after hours session. In the last 3 months the stock lost 28.43%.
NRSN-5.62%NeuroSense Therapeutics Ltd's (NASDAQ:NRSN) shares fell 5.62% to $3.19. After today's gain of 23.36%, it goes down with 5.62% in today's after hours session.
DBVT-5.49%DBV Technologies SA's (NASDAQ:DBVT) stock price is declining with 5.49% to a price of $2.41. The stock is trading 65.58% higher than a month ago.

To see the full list of after hours losers you can use our after hours losers screener.

Back

CYTOKINETICS INC

NASDAQ:CYTK (4/24/2024, 7:00:01 PM)

After market: 66 -0.82 (-1.23%)

66.82

+1.25 (+1.91%)

CYTK News

News Image8 hours ago - Cytokinetics, IncorporatedCytokinetics to Announce First Quarter Results on May 8, 2024

SOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report...

News Imagea day ago - Market News VideoNoteworthy Tuesday Option Activity: PAG, LRN, CYTK
News Image15 days ago - Cytokinetics, IncorporatedCytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Primary Results from SEQUOIA-HCM to Elaborate on Positive Topline Results in Patients with Obstructive Hypertrophic Cardiomyopathy Two Additional...

News Image20 days ago - Cytokinetics, IncorporatedCytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session

Treatment with Aficamten for 48 Weeks is Associated with Improvements in Clinical Efficacy Endpoints, NYHA Class and Cardiac Biomarkers, Structure and...

News Image22 days ago - Cytokinetics, IncorporatedCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 29, 2024 it...

News Image23 days ago - Cytokinetics, IncorporatedCytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President...

News Imagea month ago - Market News VideoCytokinetics Moves Up In Market Cap Rank, Passing Paramount Global
News Imagea month ago - Cytokinetics, IncorporatedCytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session

SOUTH SAN FRANCISCO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four presentations at the...

News Imagea month ago - The Motley Fool2 Incredible Growth Stocks to Buy Right Now

These two biotech stocks could be big winners in the years ahead.

News Imagea month ago - InvestorPlace7 Biotech Stocks Ready to Ride the Sector’s Resurgence

With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.

News Imagea month ago - Market News VideoNotable Friday Option Activity: HIBB, CYTK, SCVL
News Imagea month ago - InvestorPlace7 Biotech Stocks to Buy as Sector Rotation Ramps Up

With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.

CYTK Links
Follow us for more